{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Apoptosis role", "Leishmania tropica", "Leishmanicidal activity", "MTT assay", "Medicinal plants"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33511293", "DateRevised": {"Year": "2022", "Month": "04", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "01", "Day": "10"}], "Language": ["eng"], "ELocationID": ["e00201", "10.1016/j.parepi.2021.e00201"], "Journal": {"ISSN": "2405-6731", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021", "Month": "Feb"}}, "Title": "Parasite epidemiology and control", "ISOAbbreviation": "Parasite Epidemiol Control"}, "ArticleTitle": "The potential role and apoptotic profile of three medicinal plant extracts on <i>Leishmania tropica</i> by MTT assay, macrophage model and flow cytometry analysis.", "Pagination": {"StartPage": "e00201", "MedlinePgn": "e00201"}, "Abstract": {"AbstractText": ["Treatment of leishmaniasis with conventional synthetic drugs is a major global challenge. This study was designed to explore the leishmanicidal activity and apoptotic profile of three leaf extracts on <i>Leishmania tropica</i> stages.", "The plants of <i>Quercus velutina, Calotropis procera</i> and <i>Nicotiana tabacum</i> were gathered from Anbarabbad county, in the southeastern part of Kerman province and extracted by maceration method using methanol alcohol. Various concentrations of the extracts (1, 10, 100 and 1000\u00a0\u03bcg/mL) were used against L. <i>tropica</i> stages to evaluate the inhibitory effect by colorimetric assay, macrophage model and flow cytometry. The MTT assay was conducted to determine the IC<sub>50</sub> and CC<sub>50</sub> values in promastigotes and J774-A1 macrophages, respectively. For intra-macrophage amastigotes, the leishmanicidal activity was evaluated by calculating the mean number of amastigotes in each macrophage and also IC<sub>50</sub> values. The promastigote or amastigote stages with no drug and complete medium without organisms were considered as positive and negative controls, respectively. Meglumine antimoniate (Glucantime) was also used as standard drug. Also, annexin V was used to assess the apoptotic profile. All treatment settings were incubated for a standard time of 72\u00a0h in triplicates. Data were analyzed by <i>t</i>-test and ANOVA.", "The findings showed that all plant extracts inhibited the proliferation rate of promastigotes and amastigotes (<i>P</i> \u02c2 0.001); especially, <i>Q. velutina</i> represented the lowest IC<sub>50</sub> in both stages. Besides, <i>Q. velutina</i> showed the least number of amastigotes in each macrophage compared to the other groups (4.5\u00a0\u03bcg/mL). The percentage of parasitic apoptosis at 1000\u00a0\u03bcg/mL of <i>Q. velutina, C. procera, N. tabacum</i> and Glucantime\u00ae were 37.4, 18.6, 8.5 and 52.4, respectively. Amastigotes (clinical stage) were significantly more susceptible to extracts and also Glucantime\u00ae than promastigotes (<i>P</i>\u00a0<\u00a00.001).", "This study revealed that all three extracts of <i>Q. velutina, C. procera and N. tabacum</i> exhibited an effective antileishmanial activity and induced apoptosis against the L. <i>tropica</i> promastigotes. Further investigations are essential to isolate and analyze the chemical compositions and their biological properties."], "CopyrightInformation": "\u00a9 2021 Published by Elsevier Ltd on behalf of World Federation of Parasitologists."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Ilaghi", "ForeName": "Mozhde", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Sharifi", "ForeName": "Iraj", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Herbal and Traditional Medicines Research Center, Department of Pharmacognosy, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Sharififar", "ForeName": "Fariba", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center of Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Sharifi", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Oliaee", "ForeName": "Razieh Tavakoli", "Initials": "RT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Babaei", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Physiology and Pharmacology Department, Kerman Medical School, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Meimamandi", "ForeName": "Manzume Shamsi", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Keyhani", "ForeName": "Alireza", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Bamorovat", "ForeName": "Mehdi", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Parasite Epidemiol Control", "NlmUniqueID": "101687137", "ISSNLinking": "2405-6731"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests"}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alvar J., V\u00e9lez I.D., Bern C., Herrero M., Desjeux P., Cano J. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7", "ArticleIdList": ["PMC3365071", "22693548"]}, {"Citation": "Ashford R.W. The leishmaniases as emerging and reemerging zoonoses. Int. J. Parasitol. 2000;30:1269\u20131281.", "ArticleIdList": ["11113254"]}, {"Citation": "Azwanida N.N. A review on the extraction methods use in medicinal plants, principle, strength and limitation. Med Aromat Plants. 2015;4:412\u20132167."}, {"Citation": "Bahmani M., Saki K., Ezatpour B., Shahsavari S., Eftekhari Z., Jelodari M. Leishmaniosis phytotherapy: review of plants used in Iranian traditional medicine on leishmaniasis. Asian Pac. J. Trop. Biomed. 2015;5:695\u2013701."}, {"Citation": "Bahrami S., Khademvatan S., Razi Jalali M.H., Pourbaram S. Amiodarone triggers induction of apoptosis in cutaneous leishmaniasis agents. Pathogens and global health. 2016;110:200\u2013204.", "ArticleIdList": ["PMC5072113", "27553974"]}, {"Citation": "Bajaj S., Wakode S.R., Khan W., Manchanda S., Kumar S. Simultaneous HPTLC analysis and in vitro antileishmanic activity of various secondary metabolites in extract of the traditional medicinal herb Artabotrys hexapetalus (lf) Ayu. 2018;39:92.", "ArticleIdList": ["PMC6369602", "30783364"]}, {"Citation": "Barati M., Sharifi I., Sharififar F., Hakimi Parizi M., Shokri A. Anti-leishmanial activity of gossypium hirsutum L., Ferula Assa-foetida L. and Artemisia aucheri Boiss. Extracts by colorimetric assay. Anti-Infective Agents. 2014;12:159\u2013164."}, {"Citation": "Bruchhaus I., Roeder T., Rennenberg A., Heussler V.T. Protozoan parasites: programmed cell death as a mechanism of parasitism. Trends Parasitol. 2007;23:376\u2013383.", "ArticleIdList": ["17588817"]}, {"Citation": "Cos P., Vlietinck A.J., Vanden Berghe D., Maes L. Anti-infective potential of natural products: how to develop a stronger in vitro \u2018proof-of-concept. J. Ethnopharmacol. 2006;106:290\u2013302.", "ArticleIdList": ["16698208"]}, {"Citation": "Croft S.L., Seifert K., Yardley V. Current scenario of drug development for leishmaniasis. Indian J. Med. Res. 2006;123:399\u2013410.", "ArticleIdList": ["16778319"]}, {"Citation": "de Freitas Balanco J.M., Moreira M.E.C., Bonomo A., Bozza P.T., Amarante-Mendes G., Pirmez C. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Curr. Biol. 2001;11:1870\u20131873.", "ArticleIdList": ["11728310"]}, {"Citation": "Doroodgar M., Delavari M., Doroodgar M., Abbasi A., Taherian A.A., Doroodgar A. Tamoxifen induces apoptosis of Leishmania major promastigotes in vitro. The Korean journal of parasitology. 2016;54:9.", "ArticleIdList": ["PMC4792327", "26951973"]}, {"Citation": "El-On J. Current status and perspectives of the immunotherapy of leishmaniasis. The Israel Medical Association Journal: IMAJ. 2009;11:623.", "ArticleIdList": ["20077951"]}, {"Citation": "Ezatpour B., Saedi Dezaki E., Mahmoudvand H., Azadpour M., Ezzatkhah F. In vitro and in vivo antileishmanial effects of Pistacia khinjuk against Leishmania tropica and Leishmania major. Evid. Based Complement. Alternat. Med. 2015;2015", "ArticleIdList": ["PMC4359887", "25815025"]}, {"Citation": "Fokialakis N., Kalpoutzakis E., Tekwani B.L., Khan S.I., Kobaisy M., Skaltsounis A.L. Evaluation of the antimalarial and antileishmanial activity of plants from the Greek island of Crete. J. Nat. Med. 2007;61:38\u201345."}, {"Citation": "Harvey A.L., Edrada-Ebel R., Quinn R.J. The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 2015;14:111\u2013129.", "ArticleIdList": ["25614221"]}, {"Citation": "Lamidi M., DiGiorgio C., Delmas F., Favel A., Mve-Mba C.E., Rondi M.L. In vitro cytotoxic, antileishmanial and antifungal activities of ethnopharmacologically selected Gabonese plants. J. Ethnopharmacol. 2005;102:185\u2013190.", "ArticleIdList": ["16046090"]}, {"Citation": "Mahmoudvand H., Ezzatkhah F., Sharififar F., Sharifi I., Dezaki E.S. Antileishmanial and cytotoxic effects of essential oil and methanolic extract of Myrtus communis L. The Korean journal of parasitology. 2015;53:21.", "ArticleIdList": ["PMC4384785", "25748705"]}, {"Citation": "Moein M., Hatam G., Taghavi-Moghadam R., Zarshenas M.M. Antileishmanial activities of Greek Juniper (Juniperus excelsa M Bieb.) against leishmania major promastigotes. Journal of evidence-based complementary & alternative medicine. 2017;22:31\u201336.", "ArticleIdList": ["PMC5871199", "26747836"]}, {"Citation": "Noazin S., Modabber F., Khamesipour A., Smith P.G., Moulton L.H., Nasseri K. First generation leishmaniasis vaccines: a review of field efficacy trials. Vaccine. 2008;26:6759\u20136767.", "ArticleIdList": ["18950671"]}, {"Citation": "Rocha L.G., Almeida J., Macedo R.O., Barbosa-Filho J.M. A review of natural products with antileishmanial activity. Phytomedicine. 2005;12:514\u2013535.", "ArticleIdList": ["16008131"]}, {"Citation": "Rodrigues JCF, Seabra SH, de Souza W. Apoptosis-like death in parasitic protozoa. Journal of Morphological Sciences. 2017;23: 0."}, {"Citation": "Samuelsson G., Bohlin L. CRC Press Inc.; 2017. Drugs of Natural Origin: A Treatise of Pharmacognosy."}, {"Citation": "Schulz V., H\u00e4nsel R., Tyler V.E. Psychology Press; 2001. Rational Phytotherapy: A physician\u2019s Guide to Herbal Medicine."}, {"Citation": "Shokri A., Sharifi I., Khamesipour A., Nakhaee N., Harandi M.F., Nosratabadi J. The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate. Parasitol. Res. 2012;110:1113\u20131117.", "ArticleIdList": ["21847598"]}, {"Citation": "Tripathi A., Gupta C.M. Transbilayer translocation of membrane phosphatidylserine and its role in macrophage invasion in Leishmania promastigotes. Mol. Biochem. Parasitol. 2003;128:1\u20139.", "ArticleIdList": ["12706791"]}, {"Citation": "World Health Organization (WHO). Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, Switzerland, 22-26WHO technical report series. March 2010:2010."}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "9", "Day": "19"}, {"Year": "2020", "Month": "11", "Day": "17"}, {"Year": "2021", "Month": "1", "Day": "2"}, {"Year": "2021", "Month": "1", "Day": "29", "Hour": "5", "Minute": "58"}, {"Year": "2021", "Month": "1", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "30", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "1", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["33511293", "PMC7817489", "10.1016/j.parepi.2021.e00201", "S2405-6731(21)00002-7"]}}], "PubmedBookArticle": []}